iShares LifePath Target Date 2045 ETF (NYSEARCA:ITDE) Stock Short Interest Rises 202.2%

iShares LifePath Target Date 2045 ETF (NYSEARCA:ITDE – Get Free Report) was the target of a large growth in short interest in September. As of September 15th, there was short interest totaling 35,162 shares, a growth of 202.2% from the August 31st total of 11,634 shares. Based on an average daily volume of 30,939 shares, the days-to-cover ratio is currently 1.1 days. Currently, 1.3% of the company’s shares are sold short.

iShares LifePath Target Date 2045 ETF Stock Performance

Shares of NYSEARCA ITDE traded up $0.20 during midday trading on Friday, hitting $40.46. 8,394 shares of the company traded hands, compared to its average volume of 13,536. iShares LifePath Target Date 2045 ETF has a 12-month low of $34.81 and a 12-month high of $41.23. The firm has a market cap of $106.81 million, a P/E ratio of 20.03 and a beta of 0.81. The stock has a 50-day moving average price of $40.43 and a 200 day moving average price of $39.19.

About iShares LifePath Target Date 2045 ETF

(Get Free Report)

The iShares LifePath Target Date 2045 ETF USD (ITDE) is an exchange-traded fund that mostly invests in target date asset allocation. The fund is an actively managed fund-of-funds that invests in equity, fixed income, and money market ETFs using an asset allocation strategy that shifts exposure as the target retirement date approaches. The fund is intended for investors who anticipate retiring around 2045 ITDE was launched on Oct 17, 2023 and is issued by BlackRock.

See Also

Receive News & Ratings for iShares LifePath Target Date 2045 ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares LifePath Target Date 2045 ETF and related companies with MarketBeat.com's FREE daily email newsletter.